← SynDRA
ARANIDIPINE
SynDRA canonical compound SYN0030168 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | CACNA1C |
|---|
| Mechanism of action | l-type calcium channel blocker |
|---|
| Indication | hypertension |
|---|
| Disease area | cardiology |
|---|
All known targets
Mechanisms of action (all sources)
- l-type calcium channel blocker
- CACNA1D BLOCKER
- CACNA1C BLOCKER
Cross-references
Synonyms
- sapresta
- Aranidipino
- Sapresta
- MPC-1304
- MPC1304
- MPC 1304
- 4Y7UR6X2PO
- DTXCID6028575
- aranidipinum
- RefChem:559905
- Aranidipine [INN]
- NCGC00182054-02
- CAS-86780-90-7
- CCRIS 6724
- UNII-4Y7UR6X2PO
- Sapresta (TN)
- Aranidipine (Standard)
- Aranidipine (JAN/INN)
- ARANIDIPINE [MI]
- ARANIDIPINE [JAN]
- Aranidipine (MPC1304)
- ARANIDIPINE [MART.]
- Aranidipine (MPC1304)?
- SCHEMBL49910
- ARANIDIPINE [WHO-DD]
- orb1301842
- SCHEMBL29661509
- CHEBI:31232
- GTPL11744
- GLXC-01783
- HY-U00212R
- MPC1304;CCRIS-6724
- Tox21_113003
- AC-907
- EX-A11955
- HY-U00212
- AKOS015967075
- Tox21_113003_1
Look up ARANIDIPINE in the interactive SynDRA portal →